Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Olanzapine for schizophrenia.

L Duggan1, M Fenton, J Rathbone

  • 1Smyth Division, St Andrew's Hospital, Billing Rd, Northampton, Northamptonshire, UK, NN1 5DG. lornaduggan@yahoo.co.uk

The Cochrane Database of Systematic Reviews
|April 23, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Methodological considerations for ghrelin isoforms assay in clinical evaluation in anorexia nervosa.

Comprehensive psychoneuroendocrinology·2022
Same author

Neoadjuvant weekly paclitaxel and carboplatin with trastuzumab and pertuzumab in HER2-positive breast cancer: a Brown University Oncology Research Group (BrUOG) study.

Breast cancer research and treatment·2021
Same author

How to interpret a paediatric echocardiography report.

BJA education·2021
Same author

Characterization of a new cellulosic natural fiber extracted from the root of Ficus religiosa tree.

International journal of biological macromolecules·2019
Same author

Wide dynamic range magnetic field cycler: Harnessing quantum control at low and high fields.

The Review of scientific instruments·2019
Same author

Comparative Study of Pediatric Coronary Allograft Vasculopathy Between Single Centers in North America and United Kingdom.

Transplantation proceedings·2018

Olanzapine, an atypical antipsychotic, shows efficacy for schizophrenia with fewer extrapyramidal side effects than typical drugs, but causes significant weight gain. High participant attrition limits definitive conclusions, necessitating further long-term research.

Area of Science:

  • Psychiatry
  • Pharmacology
  • Clinical Trials

Background:

  • Olanzapine is an atypical antipsychotic used for schizophrenia.
  • It is associated with fewer extrapyramidal side effects compared to older typical antipsychotics.

Purpose of the Study:

  • To evaluate the clinical effects and safety of olanzapine.
  • Comparisons were made against placebo, typical antipsychotics, and other atypical antipsychotics for schizophrenia and schizophreniform psychoses.

Main Methods:

  • A systematic review and meta-analysis of randomized clinical trials (RCTs) was conducted.
  • Data from 55 trials involving over 10,000 participants were analyzed.
  • Outcomes included clinical response, adverse effects, and weight changes.

Related Experiment Videos

Main Results:

  • Olanzapine showed superiority over placebo in achieving 'no important clinical response' at six weeks.
  • Compared to typical antipsychotics, olanzapine demonstrated similar efficacy but fewer extrapyramidal side effects, with significant weight gain observed.
  • Olanzapine showed comparable efficacy to other atypical antipsychotics, with a trend towards fewer extrapyramidal side effects but more weight gain.

Conclusions:

  • High attrition rates in trials complicate definitive conclusions regarding olanzapine's long-term effects.
  • Olanzapine may offer antipsychotic benefits with reduced extrapyramidal symptoms but increased weight gain compared to typical drugs.
  • Further large-scale, long-term randomized trials with comprehensive data are needed.